elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany.
Worrying balance sheet with weak fundamentals.
Share Price & News
How has elexxion's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: E8X's share price has been volatile over the past 3 months.
7 Day Return
DE Medical Equipment
1 Year Return
DE Medical Equipment
Return vs Industry: E8X underperformed the German Medical Equipment industry which returned 23.4% over the past year.
Return vs Market: E8X underperformed the German Market which returned 8.1% over the past year.
Price Volatility Vs. Market
How volatile is elexxion's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is elexxion undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether elexxion is trading at an attractive price based on the cash flow it is expected to produce in the future. But as elexxion has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
- Take a look at our analysis of E8X's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through elexxion regulatory filings.
- Explore potentially undervalued companies in the Healthcare industry.
How is elexxion forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as elexxion has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of E8X’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- elexxion competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has elexxion performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: E8X is currently unprofitable.
Growing Profit Margin: E8X is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: E8X is unprofitable, and losses have increased over the past 5 years at a rate of 15.6% per year.
Accelerating Growth: Unable to compare E8X's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: E8X is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.6%).
Return on Equity
High ROE: E8X's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is elexxion's financial position?
Financial Position Analysis
Short Term Liabilities: E8X has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: E8X has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: E8X is debt free.
Reducing Debt: E8X's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if E8X has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if E8X has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is elexxion current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate E8X's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate E8X's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if E8X's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if E8X's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of E8X's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Xianlin Song (58 yo)
Mr. Xianlin Song is Chairman of the Management Board of elexxion AG since November 2017. He is Chairman of the Management Board of Tian Ying Medical. He holds a Bachelor's degree in clinical medicine.
|Co-Founder and Member of Clinical Advisory Board||no data||no data||no data|
|Member of Supervisory Board||10.08yrs||no data||no data|
|Chairman of the Supervisory Board||2.75yrs||no data||no data|
|Member of Supervisory Board||2.75yrs||no data||no data|
Experienced Board: E8X's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
elexxion AG's company bio, employee growth, exchange listings and data sources
- Name: elexxion AG
- Ticker: E8X
- Exchange: DB
- Founded: 2002
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €3.859m
- Shares outstanding: 9.90m
- Website: https://www.elexxion.com
Number of Employees
- elexxion AG
- Otto-Hahn-Strasse 7
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|E8X||DB (Deutsche Boerse AG)||Yes||Bearer Shares||DE||EUR||Oct 2006|
|E8X||XTRA (XETRA Trading Platform)||Yes||Bearer Shares||DE||EUR||Oct 2006|
elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. It offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/08 20:31|
|End of Day Share Price||2020/08/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.